EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the Senescence-Associated Secretome in Middle-Aged and Older Adults With Obesity and Prediabetes in an 18-Week Randomized Controlled Trial

Jamie N Justice iD, Xiaoyan I Leng, Nathan K LeBrasseur, Tamara Tchkonia, James L Kirkland, Natalia Mitin, Yongmei Liu, Stephen B Kritchevsky iD, Barbara J Nicklas, Jingzhong Ding

The Journals of Gerontology: Series A · 2024

DOI: 10.1093/gerona/glad214 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journals of Gerontology: Series A, 2024. Verfasst von Jamie N Justice und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Caloric Restriction, Prediabetic State. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence is a biological aging process that is exacerbated by obesity and leads to inflammation and age- and obesogenic-driven chronic diseases including type 2 diabetes. Caloric restriction (CR) may improve metabolic function in part by reducing cellular senescence and the pro-inflammatory senescence-associated phenotype (SASP). We conducted an ancillary investigation of an 18-week randomized controlled trial (RCT) of CR (n = 31) or Control (n = 27) in 58 middle-aged/older adults (57.6 ± 5.8 years; 75% Women) with obesity and prediabetes. We measured mRNA expression of select senescence and apoptosis genes in blood CD3 + T cells (qRT-PCR) and a panel of 25 plasma SASP proteins (Luminex/multiplex; ELISA). Participants randomized to CR lost −10.8 ± 0.9 kg (−11.3% ± 5.4%) over 18 weeks compared with +0.5 ± 0.9 kg (+0.03% ± 3.5%) in Control group. T-cell expression of senescence biomarkers, p16INK4a and p21CIP1/WAF1, and apoptosis markers, BCL2L1 and BAK1, was not different between CR and Control groups in age, race, and sex-adjusted mixed models (p > .05, all). Iterative principal axis factor analysis was used to develop composite SASP Factors, and the Factors comprising TNFRI, TNFRII, uPAR, MMP1, GDF15, OPN, Fas, and MPO were significantly altered with CR intervention (age, sex, race-adjusted mixed model time × treatment F = 4.17, p ≤ .05) and associated with the degree of weight loss (R2 = 0.12, p ≤ .05). Our study provides evidence from an RCT that specific circulating biomarkers of senescent cell burden are changed by CR in middle-aged and older adults with obesity and prediabetes. Future studies compare tissue and circulating levels of p16INK4a and pro-inflammatory SASP biomarkers in other populations, and interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caloric RestrictionPrediabetic StateFemaleHumansMiddle AgedAgedMaleSecretomeCyclin-Dependent Kinase Inhibitor p16Cellular SenescenceBiomarkersObesity

Stichwörter der Autor:innen

AgingBiomarkersCell senescenceDietary restrictionInflammation

Substanzen

Cyclin-Dependent Kinase Inhibitor p16Biomarkers

Autor:innen und Institutionen

  • Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

ORCID-Profile: Jamie N Justice, Stephen B Kritchevsky

Förderung

  • NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • Jason Pharmaceuticals, Inc
  • Jarrahi Research Scholars Fund in Geroscience Innovation
  • National Center for Advancing Translational Sciences

Zitieren

APA

Justice, J. N., Leng, X. I., LeBrasseur, N. K., Tchkonia, T., Kirkland, J. L., Mitin, N., Liu, Y., Kritchevsky, S. B., Nicklas, B. J., & Ding, J. (2024). Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the Senescence-Associated Secretome in Middle-Aged and Older Adults With Obesity and Prediabetes in an 18-Week Randomized Controlled Trial. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glad214

Vancouver

Justice JN, Leng XI, LeBrasseur NK, Tchkonia T, Kirkland JL, Mitin N, et al. Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the Senescence-Associated Secretome in Middle-Aged and Older Adults With Obesity and Prediabetes in an 18-Week Randomized Controlled Trial. The Journals of Gerontology: Series A. 2024. doi:10.1093/gerona/glad214

BibTeX
@article{Justice2024,
  author = {Justice, Jamie N and Leng, Xiaoyan I and LeBrasseur, Nathan K and Tchkonia, Tamara and Kirkland, James L and Mitin, Natalia and Liu, Yongmei and Kritchevsky, Stephen B and Nicklas, Barbara J and Ding, Jingzhong},
  title = {Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the Senescence-Associated Secretome in Middle-Aged and Older Adults With Obesity and Prediabetes in an 18-Week Randomized Controlled Trial},
  journal = {The Journals of Gerontology: Series A},
  year = {2024},
  doi = {10.1093/gerona/glad214}
}
Kostenlos starten →